Dr. Thomas E. Angelini is an associate professor in the department of Mechanical and Aerospace Engineering at the University of Florida. In 2005, Dr. Angelini received his PhD in physics from the University of Illinois, studying self-assembly of proteins, lipids, DNA and viruses, using techniques like small angle x-ray scattering (SAXS), cryo-electron microscopy, and confocal microscopy.
Dr. Bhumiratana has over a decade of experience in biological research, and biomedical engineering. His work has spanned from research in protein engineering, the shrimp genome project, eye tissues, and cell culturing.
Richard Billo was appointed Associate Vice President for Research in 2013, where he manages Notre Dame Research Development. In addition to this role, he is a Professor in the Department of Computer Science and Engineering, with research interests in advanced manufacturing and information systems.
Marcie Black is CEO and co-founder of Advanced Silicon Group. Dr. Black brings to the company expertise in building strong teams, managing development projects, patents, IP strategy, encouraging a healthy company culture, cost modeling, and running a startup.
Ryan Downs is a Vice President with MPR Associates, Inc. Mr. Downs joined MPR in 1997 and has since led technology and product development projects for medical device companies, pharmaceutical companies, large hospital systems, US military and other Federal Government agencies.
Dr. Francis is a proven biotechnology professional with a passion and prowess for translational science & regenerative medicine. Dr. Francis is a cultivated communicator, educator and energizer offering 20 years of diverse R&D and leadership experience spanning cardiovascular, orthopedic, spine, craniofacial and sports medicine indications.
Steve Geelhood is the Business Director at Blood Cell Storage, Inc. (BCSI). He is also the inventor of BCSI's noninvasive fluorescent pH detection technology.
Paul Goodwin is the Science Director for GE Healthcare’s Life Sciences business, located in the Seattle, WA area. Paul received his Bachelor’s degree in Biology from the University of California, San Diego and continued his education in the Department of Physiology and Biophysics at the University of Washington, Seattle, WA where he obtained a Master’s degree.
Michael Graffeo is CEO and Co-founder of FluidForm, a leader in 3D bioprinting of cells and biologic scaffolds for engineering functional human tissues. He is an accomplished Senior Executive, with more than 20 years of success across the medical device, pharmaceutical, and biotechnology industries.
Kevin Hannigan oversees all aspects of ACC and Lab Owl operations. He defines business development strategy and company initiatives for customer solutions, as well as sets goals for ACC’s product development and market focus. Kevin has a long history managing large multi-discipline projects and adopting new industries and technologies into ACC’s portfolio of offerings.